Document is current
Any future updates will be listed below
-
Authors
Feng, Xili
Xu, Liwen
Zhang, Chengqi
Zhou, Jianhua
Bai, Xue
-
Funding
Funding for this research was provided by:
National Key Research and Development Program Project (2023YFD1800700)
Jilin Provincial Scientific and Technological Development Program of China (No. 20250202056NC)
- License Information
-
More Information
Article History
Received: 1 May 2026
Accepted: 15 June 2026
First Online: 23 June 2026
Declarations
Ethics approval and consent to participate: This study was conducted in accordance with the ethical principles outlined in the "Ethical Review Measures for Life Science and Medical Research Involving Human Subjects of the People's Republic of China." According to the principles summarized in Article 32 of Chapter 3 regarding ethical review, this study is exempt from requiring ethical approval as it utilizes publicly available and anonymized data. Since the data does not involve identifiable personal information, there are no concerns regarding informed consent or privacy risks. As our research employs publicly available, anonymized data from the National Center for Biotechnology Information (NCBI) databases, such as GenBank, formal ethical approval was not necessary. However, we adhered to all applicable ethical guidelines to ensure the integrity and confidentiality of the data.
Consent for publication: Not applicable.
Competing interests: The authors declare no competing interests.
